Limited deep lung performance
For systemic delivery, particle sizes of around 1-3µm
are required in order to reach the deep lung. The
deagglomeration approaches of existing passive
inhalers, however, are not efficient enough to break
all the agglomerates down into primary particles,
and so the majority of the drug does not reach
the deep lung